Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)

• POYNARD T

収録刊行物

• Lancet

  Lancet 352 1426-1432, 1998

詳細情報

• CRID: 1572261550482010752
• NII論文ID: 10021270302
• データソース種別:
  • CiNii Articles